Clinical Trial Update: Study of Efficacy & Safety of Oral YM087 in Subjects With Euvolemic or Hypervolemic Hyponatremia [Phase 3]

View source ↗

Summary

Phase 3 study evaluating the efficacy and safety of oral YM087 in adults with euvolemic or hypervolemic hyponatremia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyponatremia

Drugs mentioned

• YM087

Snippet

Sponsor: Cumberland Pharmaceuticals | Conditions: Hyponatremia | Phase 3 | Status: COMPLETED